The Asia Pacific typhoid fever vaccines market is expected to reach US$ 135.79 million in 2027 from US$ 64.75 million in 2019. The market is estimated to grow with a CAGR of 10.0%from 2020-2027.
Key factors that are driving growth of the market are rising prevalence of typhoid, and increase in support for typhoid immunization. However, side-effects associated with typhoid fever vaccines hinder the Asia Pacific Typhoid Fever Vaccines market growth.
Typhoid fever is the most common bacterial infection among the Asian countries. Enteric fever is transmitted through contaminated food and water with human waste. Due to poor sanitation facilities in Asian countries, the prevalence of typhoid in Asian countries is high.
According to the recent estimates of the World Health Organization (WHO), typhoid is an endemic fever in Africa, Asia, Latin America, Oceania, and the Caribbean. The WHO also states that 80% of the typhoid fever cases arise from India, Bangladesh, China, Laos, Nepal, Indonesia, Vietnam, and Pakistan.
Furthermore, as per the study ‘Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities’ published in 2019, about seven million people are infected with typhoid each year in South Asia with around 75 000 deaths. As per the recent study by the All India Institute of Medical Sciences (AIIMS), around 494 per 100,000 children of age group 5–15 years suffered from typhoid in 2017.
Thus, the growing incidence of enteric fever (typhoid) in Asian countries is likely to drive the demand for typhoid vaccines in Asian countries during the forecast period.
Furthermore, Countries in the Asia Pacific are facing challenges due to increasing incidences of COVID-19. As per the data of Worldometer, as of counts as of October 06, 2020, China reported 85,482 COVID-19 cases, while in Japan, it stood at 85,739, India recorded 6,685,082 cases, and Australia reported 27,173 confirmed cases. In India, which reported a new daily high of 70,000 cases, nearly a dozen states have imposed a partial lockdown in high-risk areas. The outbreak has severely affected the tourism industry and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent disease transmission.
Rest of Asia Pacific Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Asia Pacific Typhoid Fever Vaccines – Market Segmentation
- Live Attenuated Vaccine
- Capsular Polysaccharide Vaccines
- Conjugate Vaccine
- Others
By Route of Administration
- Oral
- Injectable
By Country
- China
- Japan
- South Korea
- Australia
- India
- Rest of Asia Pacific
Company Profiles
- GlaxoSmithKline plc
- Shanghai institute of biological products co. Ltd.
- PT Bio Farma
- BIO-MED
- BHARAT BIOTECH
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Vaccine Type and Route of administration and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Typhoid Fever Vaccines Market – By Vaccine Type
1.3.2 Asia Pacific Typhoid Fever Vaccines Market – By Route of Administration
1.3.3 Asia Pacific Typhoid Fever Vaccines Market – By Country
2. Asia Pacific Typhoid Fever Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Typhoid Fever Vaccines Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific Typhoid Fever Vaccines Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Typhoid Fever Vaccines Market Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Typhoid Fever in Asia
5.1.2 Typhoid Immunizations Programs
5.2 Key Restraints
5.2.1 Risks Associated with Typhoid Fever Vaccines
5.3 Key Market Opportunities
5.3.1 Growing Pharmaceutical and Biopharmaceutical Industry in Asia
5.4 Future Trend
5.4.1 Product Development and Launches in the Asia Pacific Region
5.5 Impact Analysis
6. Typhoid Fever Vaccines Market – Asia Pacific Analysis
6.1 Asia Pacific Typhoid Fever Vaccines Market Revenue Forecasts and Analysis
7. Typhoid Fever Vaccines Market – By Vaccine Type
7.1 Overview
7.2 Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
7.3 Live Attenuated Vaccine
7.3.1 Overview
7.3.2 Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Capsular Polysaccharide Vaccines
7.5.1 Overview
7.5.2 Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Conjugate Vaccine
7.6.1 Overview
7.6.2 Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
8. Typhoid Fever Vaccines Market Analysis – By Route of Administration
8.1 Overview
8.2 Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
8.2.1 Oral
8.2.1.1 Overview
8.2.2 Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Injectable
8.3.1 Overview
8.3.2 Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9. Typhoid Fever Vaccines Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 Asia Pacific: Typhoid Fever Vaccines Market
9.1.1 Overview
9.1.2 Asia Pacific: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 Asia Pacific: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.4 Asia Pacific: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.1.5 Asia Pacific: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)
9.1.6 China: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 China: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 China: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.6.3 China: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.1.7 Japan: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Japan: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Japan: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.7.3 Japan: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.1.8 India: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 India: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 India: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.8.3 India: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.1.9 South Korea: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.1 South Korea: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.2 South Korea: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.9.3 South Korea: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.1.10 Australia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.1 Australia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.2 Australia: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.10.3 Australia: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.1.11 Rest of Asia-Pacific: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.11.1 Rest of Asia-Pacific: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.11.2 Rest of Asia-Pacific: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.11.3 Rest of Asia-Pacific: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market
10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 Shanghai Institute of Biological Products Co., Ltd.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 PT Bio Farma
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 BIO-MED
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bharat Biotech
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 GlaxoSmithKline plc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 3. China Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 4. China Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 5. Japan Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Japan Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 7. India Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 8. India Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 9. South Korea Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 10. South Korea Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 11. Australia Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Australia Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 13. Rest of Asia-Pacific Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Rest of Asia-Pacific Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 1. Glossary of Terms, Asia Pacific Typhoid Fever Vaccines Market
LIST OF FIGURES
Figure 1. Typhoid Fever Vaccines Market Segmentation
Figure 2. Asia Pacific Typhoid Fever Vaccines Market Overview
Figure 3. Capsular Polysaccharide Vaccines Segment Held Largest Share of Typhoid Fever Vaccines Market
Figure 4. Asia Pacific Typhoid Fever Vaccines Market- Leading Country Markets (US$ Mn)
Figure 5. Asia Pacific : PEST Analysis
Figure 6. Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraints
Figure 7. Asia Pacific Typhoid Fever Vaccines Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 8. Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
Figure 9. Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 10. Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 14. Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Asia Pacific: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)
Figure 17. Asia Pacific Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 18. China: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 19. Japan: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 20. India: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 21. South Korea: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 22. Australia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 23. Rest of Asia-Pacific: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in Asia Pacific Countries
- GlaxoSmithKline plc
- Shanghai institute of biological products co., Ltd
- PT Bio Farma
- BIO-MED
- BHARAT BIOTECH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Typhoid Fever Vaccines Market
Nov 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Nov 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Nov 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)